A popular but controversial supplement is back in the national spotlight. The FDA announced new moves to restrict a powerful compound found in some kratom products, saying it's as strong as morphine with no regulation. Evyn Moon reports.
Breakdown
- FDA announces intent to classify kratom compound 70 H as a schedule one controlled substance. 45s
- 70 H is described as a potent opioid, more powerful than other kratom components. 1m 9s
- Some experts support regulation, citing risks of unregulated access. 1m 44s
- Critics argue there is no evidence of deaths linked to 70 H and question the need for strict regulation. 2m 0s
- A final rule will follow a review and public comment period by the DEA. 2m 52s